Evidence map›Paper›PMID 35517997›Full record

ArticleRSC advances2019

Gold nanoparticle coatings as efficient adenovirus carriers to non-infectable stem cells.

Yulan Hernandez, Rebeca González-Pastor, Carolina Belmar-Lopez, Gracia Mendoza, Jesus M de la Fuente, Pilar Martin-Duque

Erratum issuedAbstract read
In one paragraph

Article in RSC advances, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Yulan HernandezInstituto de Nanociencia de Aragón (INA), Universidad de Zaragoza 50018 Spain.
Rebeca González-PastorInstituto Aragonés de Ciencias de la Salud 50009 Zaragoza Spain mpmartind.iacs@aragon.es.ORCID https://orcid.org/0000-0002-5630-6645
Carolina Belmar-LopezInstituto Aragonés de Ciencias de la Salud 50009 Zaragoza Spain mpmartind.iacs@aragon.es.
Gracia MendozaInstituto de Nanociencia de Aragón (INA), Universidad de Zaragoza 50018 Spain.ORCID https://orcid.org/0000-0003-2293-363X
Jesus M de la FuenteInstituto de Ciencias de Materiales (ICMA), CSIC 50009 Zaragoza Spain.
Pilar Martin-DuqueInstituto Aragonés de Ciencias de la Salud 50009 Zaragoza Spain mpmartind.iacs@aragon.es.ORCID https://orcid.org/0000-0003-4160-9720

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mesenchymal stem cells (MSCs) are adult pluripotent cells with the plasticity to be converted into different cell types. Their self-renewal capacity, relative ease of isolation, expansion and inherent migration to tumors, make them perfect candidates for cell therapy against cancer. However, MSCs are notoriously refractory to adenoviral infection, mainly because CAR (Coxsackie-Adenovirus Receptor) expression is absent or downregulated. Over the last years, nanoparticles have attracted a great deal of attention as potential vehicle candidates for gene delivery, but with limited effects on their own. Our data showed that the use of positively charged 14 nm gold nanoparticles either functionalized with arginine-glycine-aspartate (RGD) motif or not, increases the efficiency of adenovirus infection in comparison to commercial reagents without altering cell viability or cell phenotype. This system represents a simple, efficient and safe method for the transduction of MSCs, being attractive for cancer gene and cell therapies.

Identifiers

PMID35517997
PMCPMC9059632

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.